Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.263EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.135EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.219EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.125.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.78 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.159EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.443EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBNEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.462EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.147EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.6 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.5 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.4 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.420EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.233EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.320EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.635EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.19 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.15 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.113EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.423EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.109EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.361EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used